Milbon Co.,Ltd. FY2026 Q2 Earnings Report

Quick View

Executive Summary

The Company reported higher revenue and substantially higher profit, with a clear sharp recovery in profitability. Revenue was ¥268.8B (+8.3% YoY), Operating Income was ¥33.5B (+72.7%), Ordinary Income was ¥35.0B (+88.8%), and Net Income was ¥24.2B (+476.5%). Under a highly profitable structure with a gross profit margin of 63.8%, the absorption of SG&A expenses progressed, resulting in profit growth exceeding revenue growth. The reversal of temporary factors, including the investment securities valuation loss incurred in the previous year, also contributed to the substantial increase in Net Income.

Factors Affecting Performance

【Revenue】Revenue was ¥268.8B, representing an 8.3% increase year on year. Although the Company has not disclosed detailed breakdowns by region or product due to its business structure, which consists of a single segment focused on the manufacture and sale of cosmetics, it secured solid sales centered on demand for professional-use cosmetics.

【Profit and Loss】Operating Income was ¥33.5B (+72.7%), and Ordinary Income was ¥35.0B (+88.8%), achieving profit growth well above the revenue growth rate. The Operating Income margin was 12.5%, a substantial improvement from approximately 7.8% in the same period of the previous year. Although the Company recorded an impairment loss of ¥1.3B as an extraordinary loss, the gap between Ordinary Income of ¥34.99B and Net Income of ¥24.16B was primarily attributable to the ¥9.6B burden of income taxes and other taxes, resulting in an effective burden of approximately 28% against Pre-Tax Income of ¥33.7B. In the same period of the previous year, extraordinary losses were significant at ¥7.6B due to investment securities valuation losses and other factors, and this reversal was also a factor behind the sharp increase in Net Income (+476.5%) this period. In conclusion, the Company achieved higher revenue and profit, characterized by margin improvement resulting from the realization of operating leverage.

Segment Analysis

The Company operates a single segment comprising the manufacture and sale of cosmetics and does not disclose revenue or profit and loss by segment.

Key Financial Metrics

【Profitability】The Operating Income margin of 12.5% and Net Income margin of 9.0% both improved substantially from the same period of the previous year (Operating Income margin of approximately 7.8% and Net Income margin of approximately 1.7%). The gross profit margin remained high at 63.8%, securing a high profit margin even after absorbing an SG&A expense ratio of 51.3%.【Cash Flow Quality】OCF was ¥30.7B, equivalent to 1.27 times Net Income, indicating solid cash backing for earnings. However, OCF remained at 0.68 times EBITDA of ¥45.4B, with the ¥14.4B increase in inventories constraining cash conversion.【Investment Efficiency】ROE was 4.8%; despite the improvement in the Net Income margin to 9.0%, the low total asset turnover ratio of 0.45 times constrained capital efficiency. Capital expenditures of ¥8.1B were below depreciation and amortization expenses of ¥11.9B, resulting in a capital expenditure/depreciation ratio of 0.68 times.【Financial Soundness】With an Equity Ratio of 83.9%, a current ratio of 361.2%, and a D/E ratio of 0.19 times, the financial foundation is extremely conservative and robust.

Cash Flow Analysis

OCF was ¥30.7B, increasing 109.7% year on year and demonstrating cash generation exceeding Net Income of ¥24.2B. In terms of working capital, inventories increased by ¥14.4B, exerting downward pressure on OCF, while the ¥4.1B decrease in trade receivables and ¥5.3B increase in trade payables partially offset this effect. Investing CF was an outflow of ¥8.9B, primarily consisting of ¥8.1B in capital expenditures, which remained below depreciation and amortization expenses of ¥11.9B. Financing CF was an outflow of ¥15.2B, mainly attributable to dividend payments. Free cash flow was positive at ¥21.9B, indicating that these outflows were covered by funds generated from operating activities. Overall, cash generation has improved, but the decline in cash conversion efficiency due to the increase in inventories warrants attention going forward.

Earnings Quality

Profit growth this period was largely driven by improved earnings power in the core business, and the quality of recurring earnings is sound. Non-operating income was ¥1.5B, equivalent to only 0.6% of revenue, indicating low reliance on non-recurring factors such as dividends received and foreign exchange gains. The Company recorded an impairment loss of ¥1.3B as an extraordinary loss, representing a temporary factor equivalent to 5.2% of Net Income. Against Ordinary Income of ¥34.99B, Net Income was ¥24.16B, with the difference primarily attributable to the ¥9.6B burden of income taxes and other taxes. Since OCF exceeded Net Income, accruals (the divergence between accrual-basis earnings and cash earnings) were limited, and earnings quality can also be considered high from the perspective of cash backing. However, the increase in inventories partially offset OCF growth, and attention should be paid to the risk of future earnings volatility through inventory valuation.

Earnings Forecast and Guidance

Progress against the full-year Company plan was 48.3% for revenue, 51.1% for Operating Income, and 51.9% for Ordinary Income, all of which were around or slightly above the standard progress level of 50%. The full-year plan calls for revenue of ¥556.0B (+5.2% YoY), Operating Income of ¥65.5B (+15.9%), and Ordinary Income of ¥67.4B (+23.5%), while the first-half Operating Income growth rate (+72.7%) substantially exceeded the growth rate under the full-year plan. The earnings forecast was revised during the quarter, apparently reflecting the strong first-half progress. The full-year plan does not assume a growth rate as high as that achieved in the first half, making whether the first-half pace of profit growth will continue into the second half a key focus going forward.

Shareholder Returns

The Q2 dividend was ¥40.00 per share, unchanged from ¥40 in the same period of the previous year. The Payout Ratio based on first-half Net Income of ¥24.16B (dividends only) was 53.5%. The full-year dividend forecast is ¥88.00, and no revision has been made to the dividend forecast. Based on the full-year Net Income plan of ¥46.0B, the projected full-year Payout Ratio is approximately 60.8%, expected to increase slightly from the first-half actual result of 53.5%. Free cash flow of ¥21.9B exceeded dividend payments, ensuring dividend sustainability from a cash perspective. No share repurchases were identified, and the return metric here is evaluated as the Payout Ratio.

Risk Factors

1. Inventory accumulation risk: Inventories were ¥90.6B, accounting for 15.2% of total assets, and increased by ¥14.4B during the first half. As finished goods inventories constitute the majority, the risk of discounting and valuation losses may increase in the event of demand fluctuations or an increase in SKUs.

2. Declining cash conversion efficiency: OCF remained at 0.68 times EBITDA of ¥45.4B, indicating that the increase in Operating Income has not been sufficiently converted into cash generation. The increase in inventories is the primary cause, making working capital management a key focus going forward.

3. Concern over insufficient capital investment: Capital expenditures of ¥8.1B were below depreciation and amortization expenses of ¥11.9B, resulting in a capital expenditure/depreciation ratio of 0.68 times. If this condition continues, it may affect the maintenance of future production and supply capacity.

Industry Benchmark (Reference; Company Analysis)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the Operating Income margin and Net Income margin exceeded the industry median, indicating that profitability is relatively high within the industry.

Growth and Capital Efficiency

The Revenue growth rate was slightly below the industry median, placing top-line growth in the middle range within the industry.

※Source: Company analysis

Key Takeaways from the Earnings Results

1. Operating Income increased 72.7% against an 8.3% increase in revenue, resulting in a substantial year-on-year improvement in the Operating Income margin. The realization of operating leverage against a highly profitable structure with a gross profit margin of 63.8% is evident.

2. Financial soundness is extremely conservative, with an Equity Ratio of 83.9%, a current ratio of 361.2%, and a D/E ratio of 0.19 times. While the Company has substantial loss-absorption capacity and payment capacity, ROE of 4.8% is constrained by the low total asset turnover ratio.

3. The prolonged inventory turnover period and decline in the OCF/EBITDA ratio represent working capital efficiency challenges relative to earnings growth. Trends in inventory management will be closely monitored going forward.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,538–¥1,625 at ±1% for the Cost of Equity, and ¥1,580–¥1,581 at ±0.1 for ω.

Notes:

• Net assets as of the quarter-end are used (there is a timing discrepancy with the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not forecast or guarantee the future share price.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

Milbon delivered a strong FY2026 Q2 result, with underlying operating recovery and solid cash generation despite elevated inventory intensity. Revenue increased 8.3% year on year to ¥26.88bn. Operating income rose 72.7% to ¥3.35bn, materially outpacing sales growth. Ordinary income increased 88.8% to ¥3.50bn. Net income surged 476.5% to ¥2.42bn, although the comparison benefits substantially from the prior-year ¥0.76bn loss on valuation of investment securities. Gross margin expanded by 127bp year on year to 63.8%, from 62.5% in the prior period. Operating margin expanded by 465bp to 12.5%, from 7.8%, reflecting both gross-margin improvement and tightly controlled SG&A. SG&A rose only 1.7% to ¥13.79bn against 8.3% revenue growth, demonstrating favorable operating leverage. EBITDA rose to ¥4.54bn and the EBITDA margin reached 16.9%. The annualized DuPont ROE was 9.6%, driven by a 9.0% net margin, 0.900x annualized asset turnover, and conservative 1.19x financial leverage. Operating cash flow of ¥3.07bn exceeded net income by 27%, producing a healthy 1.27x OCF/net-income ratio. Free cash flow was ¥2.19bn after ¥0.81bn of capital expenditure and supports the interim dividend profile. However, cash conversion from EBITDA was modest at 0.68x, principally reflecting working-capital absorption including a ¥1.44bn inventory increase. Reported inventory-day alerts of 170 days and 227 days, as well as a 228-day cash conversion cycle, require close monitoring because they imply substantial cash tied up in the distribution and finished-goods cycle. The balance sheet remains exceptionally liquid, with a 361.2% current ratio, 255.0% quick ratio, and only 0.19x debt-to-equity. Management has revised its full-year forecast, and first-half operating-income progress of 51.1% versus the full-year target is modestly ahead of the standard 50% mid-year pace. The principal forward implication is that the company has a sound financial base to sustain earnings growth and shareholder distributions, but maintaining profit conversion will depend on normalization of inventory intensity and adequate reinvestment in production and distribution capacity.

Profitability Analysis

Annualized DuPont ROE was 9.6%, decomposed into a 9.0% net profit margin, 0.900x asset turnover, and 1.19x financial leverage. The principal contributor to the earnings improvement was margin and operating leverage rather than leverage, as the capital structure remains conservative. Gross margin improved 127bp to 63.8%, suggesting improved pricing, product mix, manufacturing absorption, or a combination of these factors. Operating margin rose more sharply, by 465bp to 12.5%, because SG&A increased only 1.7% year on year while revenue grew 8.3%. This positive gap indicates strong fixed-cost absorption and disciplined spending relative to sales growth. EBITDA was ¥4.54bn, equivalent to a 16.9% margin, providing a useful measure of operating earnings before depreciation and amortization of ¥1.19bn. The five-factor analysis also indicates a normal tax burden, with NI/EBT of 0.716, and negligible financing drag, with EBT/EBIT of 1.008. The 9.6% annualized ROE is below a 10-15% high-quality benchmark, but it is achieved without meaningful balance-sheet leverage and is therefore operationally driven. Net income growth materially exceeded operating-profit growth because the prior-year comparison included a ¥0.76bn investment-security valuation loss; consequently, the 476.5% net-income increase should not be extrapolated as a recurring operating growth rate. Current-period profitability includes a ¥0.13bn impairment loss, equal to about 5.2% of net income, which is a limited but non-recurring charge. The sustainability of the margin expansion depends on whether gross-margin gains can persist while inventories are brought to a more efficient level.

Growth Assessment

Revenue growth of 8.3% to ¥26.88bn indicates continued top-line momentum in the cosmetics manufacturing and sales business. The stronger 72.7% increase in operating income shows that current growth is highly profitable, with operating leverage contributing meaningfully. Gross profit increased 10.5% to ¥17.14bn, faster than revenue, confirming improved gross-margin quality. The sales expansion was achieved while SG&A remained nearly flat year on year, which provides a favorable near-term earnings base. Full-year guidance calls for revenue of ¥55.60bn, operating income of ¥6.55bn, ordinary income of ¥6.74bn, and net income attributable to owners of ¥4.60bn. First-half progress against guidance is 48.3% for revenue, 51.1% for operating income, 51.9% for ordinary income, and 52.5% for net income. Operating, ordinary, and net-income progress are slightly ahead of the standard 50% first-half benchmark, while revenue progress is slightly below it; this implies that the forecast assumes a modest second-half sales acceleration but no material margin deterioration. The full-year forecast implies year-on-year growth of 5.2% in revenue, 15.9% in operating income, and 23.5% in ordinary income, indicating management expects margin expansion to continue but at a more moderate pace than the first half. The forecast revision is a constructive signal, although the direction and magnitude of the revision are not quantified in the disclosed data. Inventory growth and high inventory-day alerts are the main constraint on growth quality, as sales expansion should ultimately translate into faster inventory turnover rather than prolonged stockholding. For a beauty-products manufacturer, demand forecasting, product lifecycle management, salon-channel inventory discipline, and avoidance of finished-goods obsolescence are key determinants of sustainable growth.

Financial Health

Financial health is strong. Current assets of ¥30.82bn exceeded current liabilities of ¥8.53bn by ¥22.29bn, producing a 361.2% current ratio and ¥22.29bn of working capital. The quick ratio was also robust at 255.0%, supported by ¥12.33bn of cash and deposits and ¥5.55bn of trade receivables. Cash and deposits represented 20.6% of total assets, providing ample internal liquidity. Total liabilities were only ¥9.59bn, or 16.1% of total assets, while total equity was ¥50.16bn. The reported debt-to-equity ratio of 0.19x is conservative and substantially below the 2.0x level associated with aggressive leverage. Financial leverage in the DuPont analysis was only 1.19x, confirming that returns are not dependent on debt-funded expansion. There is no apparent short-term liquidity mismatch, as liquid current assets are substantially larger than current obligations. Trade payables increased ¥0.55bn, or 38.5% year on year, to ¥1.99bn. This payable increase provides some operating funding, but it is much smaller than the ¥1.44bn inventory build and does not offset the broader working-capital commitment. Asset retirement obligations were ¥0.92bn, equal to 9.6% of total liabilities. This high ARO/liabilities ratio is a quality alert because the obligation is material relative to the otherwise small liability base; for a cosmetics and chemical-related manufacturer, facility decommissioning and environmental remediation requirements can become more significant if sites are reconfigured or retired. The balance-sheet impact is currently manageable given the ¥50.16bn equity base and high cash balance, but the obligation raises the importance of maintaining environmental compliance and appropriately funding site-retirement commitments. PPE of ¥22.78bn represented 38.1% of total assets, illustrating a meaningful manufacturing asset base that requires adequate maintenance investment.

Notable B/S Changes

Accounts payable: +¥0.55bn (+38.5%) to ¥1.99bn - increased supplier funding partly supports working capital, but remains smaller than the ¥1.44bn inventory increase. Asset retirement obligations: ¥0.92bn, equivalent to 9.6% of total liabilities - a material environmental and facility-decommissioning obligation relative to the liability base; monitor estimate revisions and compliance-related spending.

Cash Flow Quality

Operating cash flow was ¥3.07bn, exceeding net income of ¥2.42bn and producing a strong 1.27x OCF/net-income ratio. This indicates that reported earnings were cash-backed during the first half. The accruals ratio was negative 1.1%, which is consistent with favorable cash realization rather than aggressive accrual-based earnings recognition. Free cash flow was ¥2.19bn after capital expenditure of ¥0.81bn, and it was positive despite the working-capital investment. Cash conversion, measured as OCF/EBITDA, was 0.68x and triggers the low-cash-conversion alert because less than 70% of EBITDA converted into operating cash flow. The root cause is primarily working-capital absorption, including a ¥1.44bn increase in inventories, which reduced the cash generated from otherwise improved operating profitability. This level of cash conversion can occur in consumer-product manufacturing during inventory preparation for sales growth, but it is less favorable if it persists beyond a seasonal or product-launch cycle. The investment impact is that EBITDA and operating-margin improvement should be evaluated alongside inventory normalization, because a sustained sub-0.7x cash-conversion ratio would reduce financial flexibility. Inventory days were flagged at both 170 days and 227 days in the reported quality alerts. Regardless of the measurement convention underlying those two alerts, both are well above the 60-90 day manufacturing benchmark and indicate elevated stockholding. The disclosed inventory composition includes ¥30.03bn of raw materials, ¥0.63bn of work in process, and ¥90.63bn reported under finished goods. Elevated inventory is particularly relevant in cosmetics because product refresh cycles, changing consumer preferences, and expiry or obsolescence risks can require markdowns or write-downs if sell-through slows. The cash conversion cycle was flagged at 228 days, materially above the 120-day warning threshold. The root cause is the combination of high inventory duration and the resulting capital lock-up; the impact is lower cash efficiency, potentially higher provisioning risk, and greater sensitivity to demand forecasting errors. Capital expenditure was ¥0.81bn, equivalent to 0.68x depreciation and amortization of ¥1.19bn. This triggers both underinvestment alerts because a ratio below 0.7x can indicate that maintenance and replacement investment is not fully keeping pace with asset consumption. In the near term, lower CapEx supports free cash flow; however, for a company with ¥22.78bn of PPE, persistent spending below depreciation could increase future maintenance, capacity, automation, or product-quality risks. Investing cash flow of negative ¥0.89bn also included ¥0.35bn of intangible-asset purchases, indicating that part of investment is directed to non-PPE assets.

Dividend Sustainability

The Q2 dividend was ¥40.00 per share, corresponding to a calculated first-half dividend payout ratio of 53.5%. This is below the 60% sustainability benchmark and is covered by current-period earnings. Reported free-cash-flow coverage of the interim dividend was 1.69x, indicating that free cash flow provides adequate support for the distribution. Financing cash flow was negative ¥1.52bn, principally reflecting cash dividends paid, which remains manageable against operating cash flow of ¥3.07bn and cash deposits of ¥12.33bn. The full-year forecast dividend is ¥88.00 per share, implying a ¥48.00 per-share year-end dividend after the ¥40.00 interim payment. Based on forecast EPS of ¥144.68, the implied full-year dividend payout ratio is approximately 60.8%. This is marginally above the stated 60% benchmark, but the company’s large net asset base, low leverage, positive free cash flow, and strong liquidity support dividend capacity. The key condition for sustained dividend growth is preservation of operating cash conversion, as elevated inventory and low CapEx relative to depreciation could otherwise create a future trade-off between distributions and reinvestment needs. No share repurchases are identified in the provided period data; therefore, payout ratio rather than total return ratio is the relevant shareholder-return measure.

Risk Assessment

Business risks include Inventory and product-lifecycle risk: reported inventory-day alerts of 170 days and 227 days are significantly above manufacturing benchmarks. In cosmetics, slower sell-through, changing salon and consumer preferences, and product reformulations can raise discounting, write-down, or obsolescence risk., Demand and channel risk: sales growth and margin expansion depend on continued demand from professional beauty channels and successful product mix management. A slowdown in discretionary beauty spending could reduce operating leverage., Input-cost and manufacturing risk: gross-margin gains could be pressured by packaging, chemical raw-material, energy, logistics, and labor-cost inflation if pricing or mix improvements cannot offset them., Environmental and facility-retirement risk: asset retirement obligations of ¥0.92bn equal 9.6% of liabilities. This is high relative to the liability base and makes regulatory compliance, site-remediation estimates, and plant-retirement planning material considerations., Foreign-exchange risk: the period included a ¥0.06bn FX gain. The amount is immaterial relative to operating profit, but international procurement or sales can create future translation and transaction volatility..

Financial risks include Cash-conversion risk: OCF/EBITDA of 0.68x is below the 0.7x alert threshold. Although OCF exceeded net income, continued inventory accumulation could weaken free cash flow., Reinvestment risk: CapEx/depreciation of 0.68x triggers underinvestment alerts. Sustained capital spending below depreciation could defer rather than eliminate replacement and modernization requirements., Working-capital risk: the 228-day cash conversion cycle indicates material capital tied up in operations, increasing sensitivity to changes in sales volume and inventory provisioning., Payables funding risk: trade payables rose 38.5% to ¥1.99bn. The increase is not problematic in isolation given substantial liquidity, but it should not become the primary offset to inventory funding..

Key concerns include Highest priority: convert elevated inventories into revenue and operating cash flow without margin-destructive discounting or inventory write-downs., High priority: maintain the current 12.5% operating margin while restoring cash conversion toward or above 0.9x of EBITDA., Medium priority: ensure capital expenditure returns to at least depreciation-level funding if capacity, automation, asset renewal, or regulatory investment needs increase., Medium priority: monitor environmental obligations and any change in the estimated ¥0.92bn asset retirement obligation., The financial-risk profile is mitigated by a 361.2% current ratio, 255.0% quick ratio, ¥12.33bn cash balance, and 0.19x debt-to-equity ratio..

Investment Implications

Key takeaways include Revenue growth of 8.3% and operating-income growth of 72.7% demonstrate strong operating leverage., Gross margin expanded 127bp and operating margin expanded 465bp, making margin improvement the central driver of earnings recovery., The 476.5% rise in net income overstates underlying recurring growth because the prior period included a ¥0.76bn investment-security valuation loss., Operating cash flow exceeded net income, and ¥2.19bn of free cash flow supports the dividend., The balance sheet is conservatively funded, with low leverage and substantial liquidity., High inventory days, a 228-day cash conversion cycle, and 0.68x OCF/EBITDA cash conversion are the principal quality constraints., CapEx at 0.68x depreciation improves near-term free cash flow but warrants monitoring for deferred maintenance or growth investment..

Metrics to watch include Inventory balance and reported inventory days, Cash conversion cycle and OCF/EBITDA cash conversion, Gross margin and operating margin sustainability, Second-half revenue growth required to meet the ¥55.60bn full-year sales forecast, CapEx/depreciation ratio and PPE renewal requirements, Free cash flow coverage of the forecast ¥88.00 annual DPS, Asset retirement obligation estimates and environmental compliance costs.

Regarding relative positioning, Milbon presents a financially conservative profitability profile: a 12.5% operating margin and 16.9% EBITDA margin are strong for a branded cosmetics manufacturer, while the 9.6% annualized ROE remains moderate because the company employs very limited leverage. Relative operating quality is supported by positive free cash flow and OCF exceeding net income, but working-capital efficiency is weaker than standard manufacturing benchmarks due to elevated inventory and an extended cash conversion cycle.